Cho Yun Joo, Hwang Inwoo, Park Suho, Lee Somin, Kang So Young, Kim Min-Ji, Ahn Soomin, Kim Kyoung-Mee
Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Center for Companion Diagnostics, Precision Medicine Research Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Lab Invest. 2024 Jul;104(7):102071. doi: 10.1016/j.labinv.2024.102071. Epub 2024 Apr 26.
Epstein-Barr virus-associated gastric carcinoma (EBVaGC) is characterized by prominent tumor-infiltrating lymphocytes (TILs) and has a favorable prognosis. Tertiary lymphoid structures (TLS), characterized by ectopic aggregated lymphocytes with high-endothelial venules (HEV), are associated with favorable outcomes in various solid tumors. We hypothesized that EBVaGC, characterized by intense TILs, may be closely associated with TLS or HEV. To test this hypothesis, we digitally analyzed the TLS, HEV, and TILs in 73 surgically resected advanced EBVaGCs. For HEV, dual MECA-79 and CD31 dual immunohistochemistry were performed, and the ectopic expression of MECA-79 in tumor cells was measured. In 73 patients with EBVaGC, a high-TLS ratio was found in 29 (39.7%) cases, high-tumor-associated HEV density in 44 (60.3%) cases, and high-CD8 TIL density in 38 (52.1%) cases. Ectopic tumor expression of MECA-79 was observed in 36 patients (49.3%) cases. A low-TLS ratio and tumor-associated HEV density were significantly associated with lymph node metastasis (P = .005 and .042, respectively). Ectopic MECA-79 expression was significantly associated with lymph node metastasis (P = .003). Patients with a low-TLS ratio (P = .038), low-HEV density (P = .042), and ectopic tumor MECA-79 expression (P = .032) had significantly worse prognoses. In conclusion, TLS ratio and HEV density affect the survival of patients with EBVaGC and may be related to the immune response that interrupts lymph node metastasis.
爱泼斯坦-巴尔病毒相关胃癌(EBVaGC)的特征是肿瘤浸润淋巴细胞(TILs)显著,且预后良好。三级淋巴结构(TLS)以带有高内皮微静脉(HEV)的异位聚集淋巴细胞为特征,在各种实体瘤中与良好预后相关。我们推测,以强烈TILs为特征的EBVaGC可能与TLS或HEV密切相关。为验证这一假设,我们对73例手术切除的晚期EBVaGC中的TLS、HEV和TILs进行了数字分析。对于HEV,进行了MECA-79和CD31双重免疫组织化学检测,并测量了肿瘤细胞中MECA-79的异位表达。在73例EBVaGC患者中,29例(39.7%)TLS比例高,44例(60.3%)肿瘤相关HEV密度高,38例(52.1%)CD8 TIL密度高。36例(49.3%)患者观察到肿瘤细胞异位表达MECA-79。低TLS比例和肿瘤相关HEV密度与淋巴结转移显著相关(P分别为0.005和0.042)。异位MECA-79表达与淋巴结转移显著相关(P = 0.003)。TLS比例低(P = 0.038)、HEV密度低(P = 0.042)和肿瘤细胞异位表达MECA-79(P = 0.032)的患者预后明显较差。总之,TLS比例和HEV密度影响EBVaGC患者的生存,可能与中断淋巴结转移的免疫反应有关。